Sign In
Buy BBIO
$65.48
+1.60 (+2.50%)
At Close: Jun 03, 2026
BOSTON, Oct. 27, 2020 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) and affiliate Phoenix Tissue Repair today announced that the first patient has been dosed in a Phase 2 study of BBP-589
BridgeBio Pharma (NASDAQ:BBIO) Upgraded to “Hold” by Zacks Investment Research
04:26am, Wednesday, 14'th Oct 2020
Zacks Investment Research upgraded shares of BridgeBio Pharma (NASDAQ:BBIO) from a sell rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. According to Zacks,
Ten black history events that should be taught to every pupil
01:53pm, Sunday, 11'th Oct 2020
Black History Month is a chance to introduce forgotten historical episodes into the curriculum, from the British black panthers to the Bristol bus boycott
BridgeBio Pharma aumenta la quota in Eidos Therapeutics | Invezz
10:44pm, Monday, 05'th Oct 2020
L'accordo rappresenta un premio del 41% sul prezzo di chiusura di Eidos venerdì. Le due società prevedono di concludere l'accordo nel Q1 del 2021.
BridgeBio Pharma aumentará su participación en Eidos Therapeutics en un 36,3% | Invezz
07:22pm, Monday, 05'th Oct 2020
BridgeBio Pharma Inc (NASDAQ: BBIO) dijo el lunes que aumentará su participación en Eidos Therapeutics Inc (NASDAQ: EIDX) en un 36,3% en un acuerdo en efectivo que está valorado en £134,95 millone
BridgeBio Pharma to increase its stake in Eidos Therapeutics by 36.3%.
01:45pm, Monday, 05'th Oct 2020
BridgeBio Pharma to increase its stake in Eidos Therapeutics by 36.3%. The deal represents a 41% premium on Eidos' closing price on Friday.
Nuveen Asset Management LLC Sells 55,429 Shares of BridgeBio Pharma (NASDAQ:BBIO)
07:07am, Friday, 02'nd Oct 2020
Nuveen Asset Management LLC reduced its position in shares of BridgeBio Pharma (NASDAQ:BBIO) by 14.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commissio
Handelsbanken Fonder AB Makes New $443,000 Investment in BridgeBio Pharma (NASDAQ:BBIO)
07:46am, Monday, 28'th Sep 2020
Handelsbanken Fonder AB purchased a new position in BridgeBio Pharma (NASDAQ:BBIO) in the second quarter, HoldingsChannel reports. The institutional investor purchased 13,600 shares of the company’s
Wall Street Breakfast: The Week Ahead
04:06pm, Sunday, 27'th Sep 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Alibaba, PepsiCo, Wayfair And Palantir (NYSE:AMT)
12:34pm, Saturday, 26'th Sep 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
California State Teachers Retirement System Has $3.58 Million Position in BridgeBio Pharma (NASDAQ:BBIO)
07:54am, Saturday, 26'th Sep 2020
California State Teachers Retirement System lessened its stake in shares of BridgeBio Pharma (NASDAQ:BBIO) by 3.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The ins
Leap Therapeutics Initiates Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:LPTX)
07:42pm, Friday, 25'th Sep 2020
Leap Therapeutics initiates Phase 2a trial for DKN-01. MacroGenics reports progress on MGA012 development.
Cameron Turtle Sells 2,500 Shares of BridgeBio Pharma (NASDAQ:BBIO) Stock
07:16am, Friday, 18'th Sep 2020
BridgeBio Pharma (NASDAQ:BBIO) insider Cameron Turtle sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $37.06, for a to
